Abstract

Motor neuron disease (MND) is a fatal progressive neurodegenerative disorder characterized by the breakdown of the motor system. The clinical spectrum of MND encompasses different phenotypes classified according to the relative involvement of the upper or lower motor neurons (LMN) and the presence of genetic or cognitive alterations, with clear prognostic implications. However, the pathophysiological differences of these phenotypes remain largely unknown. Recently, magnetic resonance imaging (MRI) has been recognized as a helpful in-vivo MND biomarker. An increasing number of studies is applying advanced neuroimaging techniques in order to elucidate the pathophysiological processes and to identify quantitative outcomes to be used in clinical trials. Diffusion tensor imaging (DTI) is a non-invasive method to detect white matter alterations involving the upper motor neuron and extra-motor white matter tracts. According to this background, the aim of this review is to highlight the key role of MRI and especially DTI, summarizing cross-sectional and longitudinal results of different approaches applied in MND. Current literature suggests that DTI is a promising tool in order to define anatomical “signatures” of the different phenotypes of MND and to track in vivo the progressive spread of pathological proteins aggregates.

Highlights

  • Motor neuron disease (MND) is a group of fatal neurodegenerative diseases characterized by progressive damage of the upper motor neurons (UMN) in the cortex and/or lower motor neurons (LMN) in the brainstem and spinal cord

  • The present review aims to discuss the current state of the art of magnetic resonance imaging (MRI) within different phenotypes of MND, focusing on white matter (WM) microstructural alterations, underlining the role of MRI as a tool to understand disease pathophysiology and to provide potential biomarkers for diagnosis and prognostic stratification

  • In the context of therapeutic trials, it is essential to identify a useful biomarker that might help for diagnosis, stratification and tracking the disease progression within the MND spectrum

Read more

Summary

INTRODUCTION

Motor neuron disease (MND) is a group of fatal neurodegenerative diseases characterized by progressive damage of the upper motor neurons (UMN) in the cortex and/or lower motor neurons (LMN) in the brainstem and spinal cord. Depending on the relative involvement of UMN and LMN, MND can be classified in a wide range of clinical phenotypes (including amyotrophic lateral sclerosis [ALS], primary lateral sclerosis [PLS], and progressive muscular atrophy [PMA]), characterized by different clinical presentation and progression rate. The present review aims to discuss the current state of the art of MRI within different phenotypes of MND, focusing on WM microstructural alterations, underlining the role of MRI as a tool to understand disease pathophysiology and to provide potential biomarkers for diagnosis and prognostic stratification. We highlight emerging techniques, such as graph analysis, that will likely provide further insights in disease pathogenesis and might help in monitoring disease progression

Basic Principles
DTI Signatures in ALS
Phenotyping the MND Spectrum
Clinical and Neuropsychological Correlations
Findings
DISCUSSION AND FUTURE
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.